CompletedNot applicableNCT03465488

Validating Egg-based Diagnostics and Molecular Markers for the Spread of Anthelmintic Resistance

Studying Ankylostomiasis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Ghent
Principal Investigator
Bruno Levecke, PhD
University Ghent
Intervention
Albendazole Pill 400mg (GSK)(drug)
Enrollment
1000 enrolled
Eligibility
5-18 years · All sexes
Timeline
20162019

Study locations (4)

Collaborators

Swiss Tropical & Public Health Institute

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03465488 on ClinicalTrials.gov

Other trials for Ankylostomiasis

Additional recruiting or active studies for the same condition.

See all trials for Ankylostomiasis

← Back to all trials